StockDriftsStockDriftsTop 14 Decheng Capital LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 65.21% | 6.37M | $431.2M | +0.00%(+0) | $42.37(+66.05%) | 2026-03-31 | |
| NUVB | Nuvation Bio Inc. | 16.84% | 25.95M | $111.3M | +0.00%(+0) | $2.80(+103.73%) | 2026-03-31 | |
| UPB | Upstream Bio Inc. | 3.71% | 2.72M | $24.5M | -13.31%(-418.21K) | $16.44(-54.32%) | 2026-03-31 | |
| ACRS | Aclaris Therapeutics, Inc. | 2.29% | 4.04M | $15.2M | +0.00%(+0) | $1.90(+192.87%) | 2026-03-31 | |
| AARD | AARDVARK THERAPEUTICS INC | 2.23% | 3.92M | $14.8M | +0.00%(+0) | $7.51(-24.10%) | 2026-03-31 | |
| LYEL | Lyell Immunopharma, Inc. | 2.1% | 692.0K | $13.9M | +0.00%(+0) | $20.66(-32.00%) | 2026-03-31 | |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 1.57% | 325.1K | $10.4M | -45.10%(-267.00K) | $20.49(+69.95%) | 2026-03-31 | |
| RCUS | Arcus Biosciences, Inc | 1.56% | 477.8K | $10.3M | -11.77%(-63.74K) | $13.11(+131.41%) | 2026-03-31 | |
| RVMD | REVOLUTION MEDICINES INC(NSM) | 1.37% | 93.5K | $9.1M | -53.25%(-106.50K) | $44.52(+325.04%) | 2026-03-31 | |
| EQ | Equillium Inc. | 1.34% | 4.45M | $8.9M | +0.00%(+0) | $0.73(+298.63%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +4.22% | +13.19% |
| Top 20 Holdings Unweighted | +32.96% | +135.03% |
Sign up free to track Decheng Capital LLC, compare funds side by side, and get alerts the moment positions change.